Vamicamide
Vamicamide (FK-176) is an orally active competitive mAChR antagonist that inhibits contractions induced by cholinergic nerve stimulation by preventing mAChR agonists from binding to mAChR. Vamicamide exhibits a good anti-bladder spasm effect, with a pA2 value of 6.82 in bladder tissue. Vamicamide can be used in research within the field of neurological diseases[1].
Product Specifications
CAS Number
132373-81-0
Product Name Alternative
FK-176
UNSPSC
12352005
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/vamicamide.html
Smiles
O=C(N)[C@@](C1=CC=CC=C1)(C[C@H](N(C)C)C)C2=NC=CC=C2
Molecular Formula
C18H23N3O
Molecular Weight
297.39
References & Citations
[1]Oyasu H, et al. Urinary bladder-selective action of the new antimuscarinic compound vamicamide. Arzneimittelforschung. 1994 Nov;44 (11) :1242-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CPNE3 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Olr1423 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
IL15 sgRNA CRISPR Lentivector (Human) (Target 2)
